Form D · Biotechnology
ELECTROCHEMICAL OXYGEN CONCEPTS INC
San Antonio, TX · CIK 0001436343
Offering snapshot reported Nov 18, 2022 · SEC filing
- Reported sold
- $370K Offering amount: $370K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Sep 28, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2022 | Initial | $370,000 | No comparison | 7 | SEC filing |
| Jan 22, 2021 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jan 13, 2021 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Aug 25, 2020 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Aug 28, 2019 | Initial | $2,300,000 | No comparison | 1 | SEC filing |
| May 15, 2018 | Initial | $8,710,820 | No comparison | 16 | SEC filing |
| Jul 11, 2017 | Initial | $907,500 | No comparison | 2 | SEC filing |
| Apr 16, 2014 | Initial | $70,000 | No comparison | 2 | SEC filing |
| Jun 27, 2012 | Amendment | $4,290,702 | $13,200vs May 23, 2012 | 47 | SEC filing |
| May 23, 2012 | Amendment | $4,277,502 | $425,001vs Mar 23, 2012 | 46 | SEC filing |
| Mar 23, 2012 | Amendment | $3,852,501 | $1,476,500vs Dec 15, 2011 | 43 | SEC filing |
| Dec 15, 2011 | Amendment | $2,376,001 | $377,501vs Sep 8, 2011 | 26 | SEC filing |
| Sep 8, 2011 | Initial | $1,998,500 | No comparison | 17 | SEC filing |
| Feb 24, 2011 | Amendment | $2,500,000 | $65,000vs Jan 12, 2011 | 65 | SEC filing |
| Jan 12, 2011 | Amendment | $2,435,000 | $1,445,000vs Oct 28, 2010 | 62 | SEC filing |
| Oct 28, 2010 | Amendment | $990,000 | $0vs Oct 20, 2010 | 27 | SEC filing |
| Oct 20, 2010 | Amendment | $990,000 | $178,750vs Oct 20, 2010 | 27 | SEC filing |
| Oct 20, 2010 | Amendment | $811,250 | $273,750vs Oct 20, 2010 | 20 | SEC filing |
| Oct 20, 2010 | Initial | $537,500 | No comparison | 12 | SEC filing |
| Aug 10, 2009 | Initial | $705,000 | No comparison | 19 | SEC filing |
| Jun 5, 2009 | Amendment | $732,500 | $490,000vs Apr 16, 2009 | 21 | SEC filing |
| Apr 16, 2009 | Initial | $242,500 | No comparison | Not reported | SEC filing |
| Dec 18, 2008 | Initial | $150,000 | No comparison | Not reported | SEC filing |
| May 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-465291
Source: Form D, filed Nov 18, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ted M. Buchter | Director |
| James W. De Young | Director |
| Dr. Lanny Geary | Director |
| David J. Kazynski | Director |
| Lee M. Kelley | Executive |
| Joseph Moffett | Director, Executive |
| Mark Q. Niederauer | Director, Executive |
| Jim W. Phillips | Director |
| L. Peter Smith | Director |
| James Walsh | Director |
| Jim Walsh | Director |
| Michael C. Wells | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12500 Network Blvd., Suite 310
San Antonio, TX, 78249
San Antonio, TX, 78249